Tag: Nasdaq:VTVT

September 18, 2019

vTv Therapeutics Presents Additional Positive Data from the Phase 2 Simplici-T1 Study

The study evaluated patients with type 1 diabetes and was presented at the Meeting of the European Association for the...
September 12, 2019

5 Alzheimer’s Disease Treatment Stocks on the NASDAQ

A report from Reports and Data suggests the overall Alzheimer's market will be worth US$12.43 billion by 2026.
January 13, 2019

5 Top Weekly NASDAQ Biotech Stocks: Index Up During JPM Week

Axsome Therapeutics, Checkpoint Therapeutics, Bellerophon Therapeutics, Enochian Bioscience and Equillium were last week's top gainers.
October 21, 2018

5 Top Weekly NASDAQ Biotech Stocks: MannKind Leads the Pack

MannKind, Sierra Oncology, Eiger BioPharmaceuticals, Aevi Genomic Medicine and KalVista Pharmaceuticals were last week's top gainers on the NASDAQ Biotechnology...
October 7, 2018

5 Top Weekly NASDAQ Biotech Stocks: vTv Leads with 374 Percent

vTv Therapeutics, Trevena, Cyclacel Pharmaceuticals, Paratek Pharmaceuticals and Avadel Pharmaceuticals were last week's top gainers on the NASDAQ Biotechnology Index.
June 13, 2018

vTv Therapeutics Announces Topline Results from Part B of Phase 3 STEADFAST Study

vTv Therapeutics (Nasdaq:VTVT) today announced that results from Part B of the Company’s STEADFAST Study of the investigational medication azeliragon in...